Picture of Cryo-Cell International logo

CCEL Cryo-Cell International News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapSuper Stock

Cryo-Cell International Q3 revenue, net income fall

Overview

Cryo-Cell fiscal Q3 revenue decreased 3% yr/yr to $7.83 mln

The cord blood bank firm's net income for fiscal Q3 fell to $749,000 from $1.05 mln yr/yr

Outlook

Company did not provide specific guidance for future quarters or the full year in the press release

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 Revenue$7.83 mln
Analyst Coverage The one available analyst rating on the shares is "buy" The average consensus recommendation for the healthcare facilities & services peer group is "buy" Wall Street's median 12-month price target for Cryo-Cell International Inc is $8.50, about 41.2% above its May 16 closing price of $5.00 Press Release: ID:nBw6LZvy4a For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Cryo-Cell International

See all news